陆超

1、个人简介：

陆超，男，博士，暨南大学药学院副教授，硕士研究生导师，广州市增城区创新创业领军团队（人才）项目核心成员、暨南大学学科建设优秀青年骨干人才。曾任美国南佛罗里达大学访问学者，中山大学药学院博士后。2020年进入暨南大学高端药物制剂研究院工作，师从药剂学吴传斌教授。主持国家自然科学基金、中国博士后科学基金、广州市基础研究计划基础与应用基础研究项目等多个项目。发表SCI文50余篇，H-index=20，其中以第一/通讯作者在影响因子10以上杂志发表论文11篇，中科院1区/TOP论文13篇，封面论文4篇；申请专利4项，其中2项获授权，参编专著2部，多次受邀进行学术报告。担任期刊VIEW、Acta Materia Medica、Materials Futures、hLife和《今日药学》的青年编委、Exploration推广编辑、Pharmaceutics专题顾问和Moleules客座编辑，多个SCI杂志的审稿人，国际控释协会、广东省药学会等学术组织会员，中国药物制剂大会、岭南国际药学大会组委会成员。致力于推动高端药物制剂的产业化工作，与广州新济药业等国内知名企业保持良好的互动合作。近年来，指导多名本硕博学生开展学术研究，并获国家级“大创”项目资助、优秀毕业论文、优秀壁报奖等荣誉。

2、讲授课程：

[1] 药学本科生课程：《药剂学》

[2] 药剂学研究生课程：《高等药剂学》、《药剂学概论》、《药剂学研究进展》、《科研论文写作》

3、研究方向：

新型抗菌抗肿瘤材料及制剂的开发与应用，主要涉及新型纳微米药物、可溶性微针贴片、可注射水凝胶等递药系统。

4、主持的科研项目：

[1]国家自然科学基金青年基金项目（项目编号：81803467）

[2]中国博士后科学基金面上项目（项目编号：2018M633259）

[3]广东省感染病与分子免疫病理重点实验室专项项目（项目编号：GDKL202207）

[4] 广州市基础研究计划基础与应用基础研究项目（项目编号：202102020887）

[5]暨南大学学科建设优秀青年骨干项目（项目编号：/）

[6] 暨南大学人才引进科研启动经费50万（项目编号：/）

[7] 横向课题（项目编号：/）

5、代表性论文：

[1]Jingwen Deng^#, Dongyi Xian^#, Xiaopeng Cai^#, Shaoxia Liao, Siqin Lei, Fengyan Han, Yandong An, Qing He, Guilan Quan, Chuanbin Wu, Tingting Peng,* Chao Lu*, and Honghe Zhang*. Surface-engineered vanadium carbide MXenzyme for anti-inflammation and photoenhanced antitumor therapy of colon diseases. AdvancedFunctional Materials, 2023, 2211846.（IF=19.978）

[2]Xiaoqian Feng^#, Dongyi Xian^#, Jintao Fu, Rui Luo, Wenhao Wang, Yuwei Zheng, Qing He, Zhan Ouyang, Shaobin Fang, Wancong Zhang, Daojun Liu, Shijie Tang, Guilan Quan, Jianfeng Cai, Chuanbin Wu, Chao Lu*, Xin Pan*. Four-armed host-defense peptidomimetics-augmented vanadium carbide MXene-based microneedle array for efficient photo-excited bacteria-killing. Chemical Engineering Journal, 2023, 456(15): 141121.（IF=16.744）

 [3]Yin Shi, Xiaoqian Feng, Liming Lin, Jing Wang, Jiaying Chi, Biyuan Wu, Guilin Zhou, Feiyuan Yu, Qian Xu, Daojun Liu, Guilan Quan, Chao Lu*, Xin Pan*, Jianfeng Cai*, Chuanbin Wu*. Virus-inspired surface-nanoengineered antimicrobial liposome: A potential system to simultaneously achieve high activity and selectivity. Bioactive Materials, 2021, 6(10): 3207-3217.（IF=16.874）

 [4]Maochao Zheng, Miao Pan, Wancong Zhang, Huanchang Lin, Shenlang Wu, Chao Lu*, Shijie Tang*, Daojun Liu*, Jianfeng Cai*. Poly(α-L-lysine)-based nanomaterials for versatile biomedical applications: Current advances and perspectives. Bioactive Materials, 2021, 6(7): 1878-1909.（IF=16.874）

 [5]Liming Lin, Jiaying Chi, Yilang Yan, Rui Luo, Xiaoqian Feng, Yuwei Zheng, Dongyi Xian, Xin Li, Guilan Quan, Daojun Liu, Chuanbin Wu, Chao Lu*, Xin Pan. Membrane-disruptive peptides/peptidomimetics-based therapeutics: Promising systems to combat bacteria and cancer in the drug-resistant era. Acta Pharmaceutica Sinica B, 2021, 11(9): 2609-2644.（IF=14.903）

 [6] Tingting Peng, Yangyan Chen, Wanshan Hu, Yao Huang, Minmin Zhang, Chao Lu*, Xin Pan*, Chuanbin Wu*. Microneedles for enhanced topical treatment of skin disorders: Applications, challenges, and prospects.Engineering,2023, DOI: 10.1016/j.eng.2023.05.009. （IF=12.834）

 [7] Feng Li^#, Liming Lin^#, Jiaying Chi, Hui Wang, Minqun Du, Disang Feng, Liqing Wang, Rui Luo, Hangping Chen, Guilan Quan, Jianfeng Cai, Xin Pan, Chuanbin Wu, Chao Lu*. Guanidinium-rich lipopeptide functionalized bacteria-absorbing sponge as an effective trap-and-kill system for the elimination of focal bacterial infection. Acta Biomaterialia, 2022, 148:106-118. (IF=10.633)

 [8]Yuwei Zheng^#, Yilang Yan^#, Liming Lin, Qing He, Huihui Hu, Rui Luo, Dongyi Xian, Jieyi Wu, Yin Shi, Fanpu Zeng, Chuanbin Wu, Guilan Quan*, Chao Lu*. Titanium carbide MXene-based hybrid hydrogel for chemo-photothermal combinational treatment of localized bacterial infection. Acta Biomaterialia, 2022, 142: 113-123.(IF=10.633)

 [9]Peipei Yang^#, Chao Lu^#, Wanbing Qin, Minglong Chen, Guilan Quan, Hu Liu, Lili Wang, Xuequn Bai, Xin Pan*, Chuanbin Wu*. Construction of a core-shell microneedle system to achieve targeted co-delivery of checkpoint inhibitors for melanoma immunotherapy. Acta Biomaterialia, 2020, 104: 147-157. (IF=10.633)

 [10]Chao Lu^#, Xin Li^#, Wenquan Xia, Siheng Lu, Fei Tong, Hongjun Luo, Danyan Ye, Yanmei Zhang, Daojun Liu*. Poly(ε-benzyloxycarbonyl-L-lysine)-grafted branched polyethylenimine as efficient nanocarriers for indomethacin with enhanced oral bioavailability and anti-inflammatory efficacy. Acta Biomaterialia, 2016, 49: 434-443. (IF=10.633)

 [11]Jing Wang^#, Chao Lu^#, Yin Shi, Xiaoqian Feng, Biyuan Wu, Guilin Zhou, Guilan Quan, Xin Pan*, Jianfeng Cai*, and Chuanbin Wu*. Structural superiority of guanidinium-rich four-armed copolypeptides: Role of multiple peptide-membrane interactions in enhancing bacterial membrane perturbation and permeability. ACS Applied Materials & Interfaces, 2020, 12: 18363-18374. (IF=10.383)

 [12] Minghui Wang^#, Xiaoqian Feng^#, Ruixuan Gao, Peng Sang, Xin Pan, Lulu Wei, Chao Lu*, Chuanbin Wu*, Jianfeng Cai*. Modular design of membrane active antibiotics: From macromolecular antimicrobials to small scorpion-like peptidomimetics.Journal of Medicinal Chemistry, 2021, 64(14): 9894–9905.（Featured Article）(IF=8.039)

6、代表性专利：

 [1]陆超，吴传斌. 支化抗菌聚氨基酸及其制备方法与应用. 专利号ZL201910289123.4（已授权）

 [2]吴传斌，施铟，陆超，潘昕，林莉铭.一种抗菌肽脂质体制剂及其制备方法.专利号ZL201911378739.5（已授权）

 [3]陆超，罗芮，吴传斌，潘昕，周桂玲，权桂兰.针尖液、微针贴片及其制备方法与应用.专利号：202210259218.3

 [4] 陆超，吴传斌，江玲，罗芮. 防腐保鲜商标贴及其制备方法与应用.专利号：202210814648.7.

7、学术兼职：

 [1] 期刊VIEW、Acta Materia Medica、Materials Futures、hLife和《今日药学》的青年编委、Exploration推广编辑、Pharmaceutics专题顾问和Moleules客座编辑

 [2] 期刊Molecules专刊“Novel Antimicrobial Agents: Design, Synthesis and Activity”及专刊“Microneedle-Mediated Diagnosis and Therapeutics of Diseases”主编

 [3] 《药剂学实验教程》、《先进药剂学》编委

 [4] 国际控释协会、广东省药学会等多个学术组织会员

 [5] 中国药物制剂大会等多个学术会议的组委会成员

 [6] Small、Nano Letters、Acta Biomaterialia等多个SCI杂志的审稿人

 [7] 广州新济药业顾问专家

8、联系方式：

邮箱：

地址：广东省广州市番禺区兴业大道东855号暨南大学药学院

 ResearchGate:https://www.researchgate.net/profile/Chao-Lu-20/research

 ORCID: https://orcid.org/0000-0002-2118-8888